> When an acquisition sells at the same price as money raised
The acquisition did not sell at the same price as money raised so this assertion is invalid. The article directly stated this - did you read the article you are commenting on?
"Its price tag of $80 million represents less than what it raised over the years in venture capital, according to PitchBook."
The thesis you have been hammering this tiresome thread is that a company can't possibly sell for less than the amount that's been invested in it (with the implication that buyers will then be willing to pay more than they would otherwise if it's what it takes to meet that number, which is just weird), and the very example you were discussing in fact disproves your thesis. So.
Despite having 7 years of back end experience, I've never learned vim. Is there any other editor that hits these requirement (being able to login to any server to edit text) or does every server engineer need to learn vim?
(I mostly use a mix of sublime, intellij, and vscode to edit text)
Buzzfeed is a weird Jekyll & Hyde business. They have two businesses
i) the typical buzzfeed junk - Buzzfeed - This group follows no journalism practices, steals content from other sites, doesn't attribute, writes click bait articles, rebrands ads as articles, etc.
ii) the investigate journalism department - Buzzfeed News - this team has top notch investigative journalism. They actually do tons of original research, interview and cite sources, break big stories (many of the Uber scandals were found through their original research). Basically this group follows journalism standards and actually is at the top tier of investigative journalism.
The irony is that i) and ii) are run under the same brand and the only reason why Buzzfeed can fund investigate journalism ii) is due to the b.s. content they serve from i).
it's a weird scenario where the org is both the worst and best of journalism. Bu at least they have found a sustainable, albeit sleazy, way of funding investigative journalism.
Lots of other organizations who operate this way establish two separate brands so that the sleazy one doesn't sully the other. I'm kind of surprised that Buzzfeed News hasn't ditched the "Buzzfeed" name, even if it's still run by the parent company.
Google's outcomes are pretty weak. I work at a large tech firm that has significantly higher percentages of employees who are black and/or hispanic compared to Google. We are at 2-3x the rates Google publicly reports. At my current company, I regularly work with Black employees, but when I worked at Google, I could go weeks, if not months, without working with a Black person.
You can tout all the sophisticated programs about conquering bias or what not, but the truth is many of these initiatives have shown little actual evidence for improving outcomes. Our company is probably doing 1/10 of what Google is doing with 2-3x the outcomes. One major difference I see between Google and us; we actually have offices in cities with high concentration of black and hispanic talent. While I was at Google, leadership pushed people towards the HQ and in fact they were shutting down offices that were in more diverse areas of America. You can tout all the sophisticated programs Google runs, but I believe that Google misses the most basic steps for how to increase diversity in their workforce.
Our metrics aren't great, but they are a significantly better than Google. We aren't a unicorn, I know of a handful of tech companies that are at the same level, and the common pattern I see is very basic steps towards hiring that Google refuses to consider. As an outsider (and an insider several years ago), my experience is that Google invests in lots of programs that give a credence of caring about diversity, while actively avoiding doing impactful things.
They aren't trying to force outcomes. "The interview process, while not perfect, also tries to erase bias by forcing gender and racially-neutral terms in interview writeups."
Its easy to boost your outcomes if that's what you want. You just specifically hire people of some race.
Carousel team was huge. My roommates was at Dropbox and said it was 100+ while he had a handful of engineers supporting him for enterprise features. Mailbox was another consumer investment that was largely a waste. Drew really didn't like enterprise.
my question is, what was the business value of doing a full write rather than incremental shift? same question on the specific date - was their any business value delivered by specifically launching the new app on New Year's?
If not, this rewrite basically cost huge amounts of burnout across the mobile and server teams for no business value. At best it seems like an intense learning experience that didn't actually unlock $$.
This isn't surprising to me. In India a lot of state governments are sending covid pill packs to citizens which really don't do anything for covid and contain things like hydroxychloroquine, remdesivir, zinc, other steroids, and other blood thinners.
even the AIMS protocol doesn't recommend against drugs and techniques that the rest of the world has rejected almost a year ago. My partner treats covid in the US and has been doing consults to patients in India. Most of their work is telling patients to ignore the pills their doctors or government has been sending, although they rarely listen.
I wouldn't be surprised if a large chunk of the covid negative or mild covid population is on steroids.
Systemic corticosteroids are strongly recommended for patients by WHO. I see from here https://www.indiatoday.in/coronavirus-outbreak/story/remdesi...
that also budesonide is recommended for patients with mild symptoms and the usage of is backed up by recent studies.
I do not think that the problem is steroid usage by itself but depressing lack of even basic hygiene even in hospitals.
PS. Blood thinning is standard procedure in COVID-19 care for many hospitals, dunno how reasonable at home without any tests. Remdesivir is injected, I do not believe that it is distributed. Perhaps you meant ivermectin?
Systemic corticosteroids are not prescribed for patients with mild symptoms at home in America. Basically you get acetaminophen and are asked to quarantine similar to a cold. Budesonide is not recommended in the case either. I am talking about US standards, but I think EU and UK doctors would also agree with me.
Hygiene in hospital is definitely a possibly other issue.
At least by US standards, blood thinners are not a reasonable procedure for mild symptoms either. In general India is being extremely aggress with using prescriptions, at least compared to the west and Eastern Asia. There are many examples where AIMS protocol and Indian standard guidance is contrary to WHO, NHS, and CDC guidance.
The acquisition did not sell at the same price as money raised so this assertion is invalid. The article directly stated this - did you read the article you are commenting on?
"Its price tag of $80 million represents less than what it raised over the years in venture capital, according to PitchBook."